Treatment and impact of dyslipidemia in diabetic nephropathy
スポンサーリンク
概要
- 論文の詳細を見る
Recent epidemiological research revealed that dyslipidemia is a risk factor for development and progression of diabetic nephropathy. Results from interventional studies revealed the possibility that anti-hyperlipidemic agents have a better effect on diabetic nephropathy through improvement of albuminuria and loss of renal function. In addition, dyslipidemia may be a consequence of albuminuria and renal dysfunction, thereby perpetuating kidney damage. Today, the proportion of diabetic patients receiving statins is increasing due to their beneficial effect on cardiovascular mortality. However, treatment for patients should be determined based on consideration of the risk and benefit of the treatment. More insight into the pathogenesis of diabetic nephropathy and the effects of life-style changes is required. © 2013 Japanese Society of Nephrology.
- Springer-Verlagの論文
Springer-Verlag | 論文
- Augmenting a (k-1)-vertex-connected multigraph to an l-edge-connected and k-vertex-connected multigraph
- Development of Taenia saginata asiatica metacestodes in SCID mice and its infectivity in human and alternative definitive hosts
- Effects of fire-derived charcoal on soil properties and seedling regeneration in a recently burned Larix gmelinii/Pinus sylvestris forest
- Carbon dioxide insufflation during endoscopic retrograde cholangiopancreatography reduces bowel gas volume but does not affect visual analogue scale scores of suffering: a prospective, double-blind, randomized, controlled trial
- Diversity of Freshwater Thioploca Species and Their Specific Association with Filamentous Bacteria of the Phylum Chloroflexi